Enabling Cell and Gene Therapy Delivery: Overcoming Logistics Hurdles
The pharmaceutical industry is undergoing a transformation, with cell and gene therapies (CGTs) at the forefront of innovation. These therapies, offering life-changing and often curative treatments, represent the cutting edge of modern medicine. However, their success relies not only on scientific breakthroughs but also on robust, reliable, and efficient logistics solutions. Unlike traditional medicines, CGTs are highly sensitive, patient-specific, and time-critical. As such, enabling their safe and compliant delivery is one of the greatest challenges the sector faces today.
At Arca BioLogistics, we work with pharmaceutical companies to address these challenges, providing advanced logistics solutions that protect therapy integrity while improving sustainability, reliability, and efficiency.
The Unique Challenges of Cell and Gene Therapy Logistics
Cell and gene therapies differ fundamentally from conventional pharmaceuticals. Each product is often tailored to an individual patient, meaning there is no room for error in collection, storage, or transport. Challenges include:
Temperature Sensitivity – Many therapies must be stored at ultra-low temperatures (down to -196°C in liquid nitrogen vapour), requiring specialist packaging and monitoring.
Time Criticality – Materials are often viable for only a short period, necessitating rapid, precise delivery.
Regulatory Complexity – CGTs cross borders and require strict compliance with international standards, customs regulations, and chain-of-custody protocols.
Fragility and Value – Therapies can be both physically fragile and extraordinarily high in value, making their protection during transit paramount.
With such challenges, the importance of advanced logistics systems cannot be overstated.
Sustainability: Delivering Innovation Responsibly
Pharmaceutical companies are under increasing pressure to not only deliver new treatments but also to do so in ways that align with environmental commitments. At Arca BioLogistics, sustainability is central to our operations.
Reusable Packaging and Loggers – We provide systems that can be used across multiple shipments, cutting down on waste associated with single-use packaging.
Carbon Offsetting – Clients have the option to offset the carbon emissions of each transit, allowing them to integrate logistics into their broader sustainability targets.
Minimising Material Wastage – Reliable packaging and monitoring reduce the risk of therapy spoilage, ensuring that valuable treatments reach patients without unnecessary waste.
Work with a logistics partner who shares your sustainability goals. Contact Arca today to learn about our reusable solutions and offsetting options.
By adopting sustainable logistics practices, pharmaceutical companies not only protect their therapies but also contribute to a healthier planet.
Reliability: Building Confidence in Every Shipment
In the world of cell and gene therapies, reliability isn’t a luxury – it’s a necessity. A missed deadline or temperature excursion could mean a therapy never reaches a patient in need. That’s why at Arca BioLogistics, we design logistics processes around consistency and transparency.
Arca Live Portal – Our real-time tracking platform provides complete visibility into location, temperature, and handling, offering peace of mind at every stage.
Consistent Transit Performance – With dependable booking processes, customs approvals, and predictable transit times, we reduce the uncertainty that disrupts supply chains.
Validated Processes – All routes, packaging, and handling methods are validated to ensure repeatable results, whether shipping domestically or internationally.
This level of reliability allows pharmaceutical companies to better manage their own supply chains, freeing up resources and reducing waste — both financially and in terms of productivity.
Time and Efficiency: Freeing Up Valuable Resources
Pharmaceutical companies are under growing pressure to do more with less. While logistics is crucial, it should not consume valuable time and resources from scientific and operational teams. Yet many companies find that their employees spend increasing amounts of time dealing with shipping issues, detracting from their core responsibilities.
Arca BioLogistics helps to solve this problem:
84% Reduction in Pre-Shipping Time – Thanks to the Arca Live portal and our global network of professionals, we significantly reduce administrative and preparatory burdens.
Simplified Processes – Automated workflows and expert support make booking shipments fast and frustration-free.
Dedicated Support – Our experienced team acts as a single point of contact, taking ownership of logistics challenges so your staff can focus on their priorities.
Reclaim your team’s time. Let Arca take the complexity out of your cell and gene therapy logistics.
By streamlining logistics, we not only save time but also reduce costs, improve productivity, and alleviate the stress often associated with managing such critical shipments.
Overcoming Global Regulatory Hurdles
Cell and gene therapies often involve international collaboration, requiring materials to move seamlessly across borders. However, navigating customs clearance and regulatory frameworks can be one of the most significant barriers.
At Arca BioLogistics, our expertise in global compliance ensures smoother international operations:
Customs Pre-Clearance – We prepare documentation in advance to minimise border delays.
Chain of Custody Assurance – Every hand-off is documented and monitored to ensure compliance and transparency.
Experience in Complex Environments – From the EU to emerging markets, we have the knowledge to guide therapies through regulatory challenges.
By overcoming these hurdles, we help pharmaceutical companies scale their CGT operations globally without compromising compliance or integrity.
The Human Impact: Delivering Hope Through Logistics
Behind every cell or gene therapy shipment is a patient waiting for a life-changing treatment. The stakes could not be higher. Logistics is more than moving boxes – it’s enabling hope, extending lives, and supporting medical breakthroughs.
By ensuring therapies reach their destinations intact and on time, Arca BioLogistics becomes a partner in delivering not just medicines, but outcomes that change lives.
Join us in making life-changing therapies accessible worldwide. Contact Arca to learn more about our dedicated CGT logistics solutions.
Case for Partnership: Why Arca BioLogistics?
Pharmaceutical companies need a logistics partner that understands both the science and the stakes of CGT delivery. Arca BioLogistics provides:
Sustainable Packaging Solutions – Supporting environmental responsibility.
Reliable, Validated Logistics – Ensuring therapy integrity and compliance every time.
Efficient Processes – Freeing up your teams to focus on research, development, and patient care.
Global Expertise – Overcoming cross-border challenges with confidence.
Together, these capabilities make us more than a service provider — we are a trusted partner for pharmaceutical companies committed to advancing cell and gene therapies.
Logistics as a Catalyst for Innovation
Cell and gene therapies represent the future of medicine. But their potential can only be realised if the logistical hurdles are overcome. Sustainability, reliability, and efficiency must be embedded into every shipment to ensure patients receive the treatments they urgently need.
At Arca BioLogistics, we combine advanced packaging, real-time monitoring, global expertise, and a commitment to sustainability to support the pharmaceutical industry in meeting these challenges.
If your organisation is ready to enhance its logistics processes and deliver cutting-edge therapies with confidence, Arca is ready to help.